TOCQUEVILLE ASSET MANAGEMENT L.P. - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 1 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TOCQUEVILLE ASSET MANAGEMENT L.P. ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2013$26,000
-93.3%
4,700
-92.6%
0.00%
-100.0%
Q3 2013$387,000
-34.2%
63,200
-37.2%
0.01%
-37.5%
Q2 2013$588,000100,6000.01%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 3,000,000$5,160,0004.58%
Foresite Capital Management II, LLC 6,225,049$10,707,0003.59%
Scale Management, LLC 1,312,575$2,258,0003.46%
NEA Management Company, LLC 3,709,000$6,379,0000.41%
Cheyne Capital Management (UK) LLP 413,200$709,0000.38%
Rhenman & Partners Asset Management AB 1,189,000$2,045,0000.31%
SAMLYN CAPITAL, LLC 6,160,417$10,596,0000.22%
Rock Springs Capital Management LP 1,650,000$2,838,0000.22%
Palo Alto Investors LP 1,673,024$2,878,0000.16%
GLOBEFLEX CAPITAL L P 295,000$507,0000.14%
View complete list of OREXIGEN THERAPEUTICS INC shareholders